These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2686604)

  • 21. Haemostatic parameters and vascular risk.
    Juhan-Vage I
    Atherosclerosis; 1996 Jul; 124 Suppl():S49-55. PubMed ID: 8831916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein.
    Lichtenstein AH; Erkkilä AT; Lamarche B; Schwab US; Jalbert SM; Ausman LM
    Atherosclerosis; 2003 Nov; 171(1):97-107. PubMed ID: 14642411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study.
    Tracy RP; Bovill EG; Yanez D; Psaty BM; Fried LP; Heiss G; Lee M; Polak JF; Savage PJ
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1269-79. PubMed ID: 7670938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phospholipase C sensitive FVII activity and FVII antigen in hypertriglyceridemia.
    Carvalho de Sousa J; Bruckert E; Soria C; Caen JP
    Nouv Rev Fr Hematol (1978); 1989; 31(1):13-5. PubMed ID: 2915918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration.
    Humphries SE; Lane A; Green FR; Cooper J; Miller GJ
    Arterioscler Thromb; 1994 Feb; 14(2):193-8. PubMed ID: 8305408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma phospholipid fatty acid composition and factor VII coagulant activity.
    Folsom AR; Ma J; Eckfeldt JH; Shahar E; Wu KK
    Atherosclerosis; 1994 Dec; 111(2):199-207. PubMed ID: 7718022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of long-term olive oil dietary intervention on postprandial triacylglycerol and factor VII metabolism.
    Roche HM; Zampelas A; Knapper JM; Webb D; Brooks C; Jackson KG; Wright JW; Gould BJ; Kafatos A; Gibney MJ; Williams CM
    Am J Clin Nutr; 1998 Sep; 68(3):552-60. PubMed ID: 9734730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial nutritional properties of olive oil: implications for postprandial lipoproteins and factor VII.
    Williams CM
    Nutr Metab Cardiovasc Dis; 2001 Aug; 11(4 Suppl):51-6. PubMed ID: 11894755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality.
    Miller GJ; Martin JC; Webster J; Wilkes H; Miller NE; Wilkinson WH; Meade TW
    Atherosclerosis; 1986 Jun; 60(3):269-77. PubMed ID: 3730046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of long-term diet and omega-3 fatty acid supplementation on coagulation factor VII and serum phospholipids with special emphasis on the R353Q polymorphism of the FVII gene.
    Lindman AS; Pedersen JI; Hjerkinn EM; Arnesen H; Veierød MB; Ellingsen I; Seljeflot I
    Thromb Haemost; 2004 Jun; 91(6):1097-104. PubMed ID: 15175795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary monounsaturated fatty acids and haemostasis.
    Kelly CM; Smith RD; Williams CM
    Proc Nutr Soc; 2001 May; 60(2):161-70. PubMed ID: 11681631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mild liver abnormalities associated with elevated plasma factor VII and protein C in hypertriglyceridaemic patients.
    Bruckert E; Ankri A; Jung M; Turpin G; De Gennes JL
    Eur J Med; 1993; 2(8):461-5. PubMed ID: 8258046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma level of triglyceride-rich lipoprotein remnants is closely associated with the activation of coagulation factor VII in patients with myocardial infarction.
    Saigo M; Abe S; Ogawa M; Biro S; Minagoe S; Maruyama I; Toda H; Kiyonaga K; Atsuchi Y; Tahara M; Mawatari K; Tei C
    Thromb Res; 2000 Oct; 100(1):9-17. PubMed ID: 11053611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor VII and extrinsic pathway inhibitor in acute coronary disease.
    Sandset PM; Sirnes PA; Abildgaard U
    Br J Haematol; 1989 Jul; 72(3):391-6. PubMed ID: 2788454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor VII activity state in coronary artery disease.
    Hoffman C; Shah A; Sodums M; Hultin MB
    J Lab Clin Med; 1988 Apr; 111(4):475-81. PubMed ID: 3351380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inter-relationship of factor VII and its activity state with plasma lipids in healthy male adults.
    Wright D; Poller L; Thomson JM; Gowland E; Burrows GE
    Br J Haematol; 1993 Oct; 85(2):348-51. PubMed ID: 8280607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phospholipase C-sensitive factor VII complexes in dog plasma.
    Prydz H; Spurling NW; Boyce AJ; Mifsud CV
    Thromb Res; 1991 Nov; 64(4):387-94. PubMed ID: 1788825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemostatic factors in Australian Aboriginal and Torres Strait Islander populations.
    Wang Z; Rowley K; Best J; McDermott R; Taylor M; O'Dea K
    Metabolism; 2007 May; 56(5):629-35. PubMed ID: 17445537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: relationship with dyslipidaemia, inflammation, and factor VII genotype.
    Irish AB; Green FR
    Nephrol Dial Transplant; 1998 Mar; 13(3):679-84. PubMed ID: 9550647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulation factor VII, dietary fat and blood lipids: a review.
    Mennen LI; Schouten EG; Grobbee DE; Kluft C
    Thromb Haemost; 1996 Oct; 76(4):492-9. PubMed ID: 8902983
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.